Effect of Endostar Combined With Intensity-modulated Radiotherapy Compare With Chemoradiation for Locoregionally Advanced,Low-risk Nasopharyngeal Carcinoma.
Phase of Trial: Phase II
Latest Information Update: 06 Jun 2017
Price : $35 *
At a glance
- Drugs Endostatin (Primary) ; Cis diamminediaquaplatinum
- Indications Nasopharyngeal cancer
- Focus Therapeutic Use
- 06 Jun 2017 Status changed from not yet recruiting to recruiting, based on the results presented at the 53rd Annual Meeting of the American Society of Clinical Oncology.
- 06 Jun 2017 Results (n=120) presented at the 53rd Annual Meeting of the American Society of Clinical Oncology.
- 17 Sep 2014 New trial record